Full results & analysis
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical Lidocaine Spray Before Intubation in Robotic Surgery
NCT07154628Phase 4
Key facts
- Status
- Not yet recruiting
- Start
- Sep 2025
- Primary completion
- Dec 2028
- Countries
- 1
- Sponsor
- Kaohsiung Medical University Chung-Ho Memorial Hospital
- Modality
- Small Molecules
- Drugs
- lidocaine
01
Overview
Phase 4, randomised trial of lidocaine (2 arms), sponsored by Kaohsiung Medical University Chung-Ho Memorial Hospital. Primary endpoints: Post-intubation hypertension, Changes in mean arterial pressure and 1 more. Planned start Sep 2025; status: not yet recruiting.
02
Design
2 arms- Study design
- Randomized
Lidocaine group
Lidocaine spray on vocal cords
Control group
Normal saline spray on vocal cords
03
Who it enrols
Patients scheduled for elective robotic surgery under general anesthesia with ASA classification I-III. Excludes patients with allergy or contraindication to lidocaine.
04
Endpoints
Primary
Post-intubation hypertension
Changes in mean arterial pressure
Surgical Pleth Index
Secondary
Post-intubation hypotension
Postoperative sore throat
Pain on swallowing
Hoarseness
Beyond the preview
Go deeper on NCT07154628.
Full results, competitive context and analysis are in the Gosset platform.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07154628.